Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
Conclusions This exploratory analysis suggests that, in patients who require stenting of a large coronary artery, use of a clinical risk score may identify those patients for whom DES use may confer a clinical advantage over BMS, beyond lower restenosis rates.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Chronic Kidney Disease | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Heart Attack | Hypertension | Peripheral Vascular Disease (PVD) | Rheumatology | Smokers | Stroke | Study | Urology & Nephrology